Dunvegan Associates »

SPDR S&P Pharmaceuticals shares owned by Dunvegan Associates

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Dunvegan Associates from 13F filings

Historical chart of Dunvegan Associates investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Dunvegan Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Dunvegan Associates

Quarter filed Position value Share count Share price at filing
2015-12-31 $75k 1.5k 51.09
2015-09-30 $77k 1.6k 46.78
2015-06-30 $103k 823 125.15
2015-03-31 $102k 823 123.94
2014-12-31 $89k 823 108.14
2014-09-30 $105k 987 106.38
2014-06-30 $102k 987 103.34
2014-03-31 $92k 987 93.21